Bessemer Group’s Emergent Biosolutions EBS Stock Holding History

Bessemer Group’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-299	Closed	-$15K	–	1880
2021 Q3	$15K	Hold	299	–	–	﹤0.01%	1286
2021 Q2	$19K	Sell	299 -70	-19%	-$4.5K	﹤0.01%	1239
2021 Q1	$35K	Buy	369 +70	+23%	+$7.17K	﹤0.01%	1078
2020 Q4	$27K	Hold	299	–	–	﹤0.01%	1121
2020 Q3	$31K	Hold	299	–	–	﹤0.01%	988
2020 Q2	$24K	Buy	+299	New	+$22.3K	﹤0.01%	1433
2019 Q2	–	Sell	-33	Closed	-$2K	–	1678
2019 Q1	$2K	Sell	33 -377	-92%	-$22.2K	﹤0.01%	1669
2018 Q4	$24K	Buy	+410	New	+$26.4K	﹤0.01%	1468
2016 Q4	–	Sell	-412	Closed	-$13K	–	1970
2016 Q3	$13K	Buy	+412	New	+$12K	﹤0.01%	1468
2016 Q2	–	Sell	-116	Closed	-$4K	–	1336
2016 Q1	$4K	Sell	116 -44,488	-100%	-$1.57M	﹤0.01%	1290
2015 Q4	$1.78M	Hold	44,604	–	–	0.01%	456
2015 Q3	$1.27M	Buy	+44,604	New	+$1.47M	0.01%	517
2013 Q4	–	Sell	-4,756	Closed	-$91K	–	1347
2013 Q3	$91K	Buy	+4,756	New	+$84.9K	﹤0.01%	737

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bessemer Group's EBS Position: Q4 2021 in Review

Bessemer Group sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 299 shares — an estimated $15K sold.

Bessemer Group first reported a position in EBS in Q3 2013 and held it in 13 quarters. The position peaked at $1.78M in Q4 2015. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

Bessemer Group reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
Bessemer Group sold 299 Emergent Biosolutions shares in Q4 2021, an estimated $15K.
Bessemer Group first reported a position in Emergent Biosolutions in Q3 2013 and held it in 13 quarters.
Bessemer Group's Emergent Biosolutions position peaked at $1.78M in Q4 2015.
254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Bessemer Group's 13F filing for Q4 2021, filed 27 Jan 2022.